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2007 cohort. The median time to biopsy post-HCT was 72
days (IQR 32-89) for the early cohort and 97 days (IQR 33-
119) for the more recent cohort, for an overall biopsy inci-
dence of 0.052 and 0.02 per 1000 patient days, respectively.
Patients in the 2003-2007 cohort were less likely to undergo
a lung biopsy (HR 0.52, CI 0.28-0.98, P¼ .04) when compared
to patients in the 1993-1997 cohort. Although a similar
number of patients underwent a bronchoscopy between the
two cohorts (272/1418 [19.2%] vs. 243/1148 [21.1%], P ¼ .22),
more patients in the early cohort underwent lung biopsy
without antecedent bronchoscopy (26/52 [50%] vs. 18/21
[86%], P ¼ .007). Infections were a more common ﬁnding at
biopsy in the early cohort (35/1418 vs. 8/1148, P < .001), but
the number of biopsies demonstrating non-infectious lesions
was similar between the two cohorts (17/1418 vs. 13/1148, P
¼ .85). Fungal infections were the major infectious etiology
in both cohorts (30/35[85%] vs. 5/8 [63%], P ¼ .15), but there
was a signiﬁcant reduction in the number of Aspergillus
species found at biopsy between the cohorts (29/52 vs. 1/21,
P < .001). A similar number of patients underwent biopsy
with a therapeutic intent in the two cohorts (8/52 [15%] vs. 3/
21 [14%]); all of those who underwent therapeutic biopsy in
the 2003-2007 cohort had documented Mucorales species.
Conclusions: Surgical evaluation of lung disease in HCT
recipients signiﬁcantly declined over a decade between
1993-1997 and 2003-2007. This decreased incidence of lung
biopsies between these two cohorts was related to a reduc-
tion in the number of biopsies for post-transplant infections,
particularly for those due to aspergillosis. We speculate that
this decline is related to the introduction of galactomannan
testing and the increased use of empiric therapy with
extended-spectrum azoles.298
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Background: The BoneMarrow Transplant Unit of Cincinnati
Children's Hospital Medical Center is a crucial care and
stressful unit. The nurses not only care for complex patients
with an array of co-morbidities, but also therapeutically
support the family. This may lead to an increased workload
and increased stress levels on nurses, which can potentially
cause burnout and turnover. Resiliency training has been
shown to decrease stress levels and improve positive outlook
in stressful work environments (Pipe et al. 2012; Steinhart et
al. 2008; Burton et al. 2010; Sood et al. 2011). There is a gap in
the literature regarding speciﬁc interventions to help new
nurses cope with the stressors of a critical care environment.
Research Question Do newly hired nurses who receive
resiliency training in addition to standard orientation
improve nurse job satisfaction scores and decrease job
turnover? Purpose/Intervention The purpose of this project
is to improve the well-being and job satisfaction of the new
staff nurses on the Bone Marrow Transplant Unit at CCHMC.
Using principles founded in positive psychology, an educa-
tion program will be implemented into the orientation
schedule of newly hired nurses. Job satisfaction scores and
stress levels will be monitored before the educational
program and at 6 months and 1 year post. Data will be
collected to determine the efﬁcacy of the additional educa-
tion throughout the orientation period.299
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Background: The purpose of our study was to evaluate the
incidence and outcome of Invasive Fungal Infections (IFI)
among patients who underwent autologous or allogeneic
Hematopoietic Stem Cell Transplantation (HSCT) at our BMT-
Unit.
Methods: This cohort-retrospective study,conducted during
02/1994 to 09/2012, involved HSCT patients admitted to our
BMT-Unit, who developed IFI.The IFI were classiﬁed accord-
ing to the modiﬁed EORTC/MSG criteria.
Results: Among 369 patients who underwent HSCT(88
allogeneic HSCT recipients and 281 autologous HSCT recipi-
ents), IFI occurred in 38 patients (overall incidence 10,3 %). 34
episodes (9,2 % of all patients) were due to molds, and 4 (1 %)
were due to yeasts. 27 episodes (30,6 %) occurred among the
allogeneic HSCT recipients, and 11 (3,9%) occurred among the
autologous HSCT recipients (RR 7.83, 95%CI 3.92-16.21).
Etiological agents were Aspergillus (31 episodes), Candida
(3 episodes), Rhodotorula (1 episode), Fusarium (1 episode),
Scedosporium (1 episode), Zygomycosis (1 episode). The
incidence of Aspergillosis was 25 % and 3,2 % among allo-
geneic and autologous HSCT recipients respectively (RR 7.80,
95%CI 3.58-17.75). The incidence of Candidiasis was 2,2 % and
0,3% among allogeneic and autologous HSCT recipients
respectively (RR 6.38, 95% CI 0.45-177.57). The overall
mortality rate for IFI was 5,7% among allogeneic HSCT
recipients and 1 % among autologous recipients (RR 5.32,95%
CI 1.13-27.79), whereas the attributable mortality rate for IFI
registered in our population was 21% (18,5 % for allogeneic
HSCT recipients and 27,2 % for autologous HSCT recipients
(RR 0.67,95% CI 0.16-3.34). The attributable mortality rate for
aspergillosis was 22,6 % (18,2 % and 33,3 % for allogeneic and
autologous HSCT recipients, respectively, RR 0.54,95%CI 0.12-
2.81), and the rate for Candida IFI was 0 %.
Conclusions: IFI represents a common complication for
allogeneic HSCT recipients.Aspergillosis is the most
frequently detected IFI in these patients. Conversely, autol-
ogous HSCT recipients rarely develop aspergillosis. Candi-
demiawas observed less often than aspergillosis among both
allogeneic and autologous HSCT recipients.
300
A Single Daily Ultra Low-Dose of Oral Acyclovir Is
Sufﬁcient to Prevent the Occurrence of Herpes Zoster
Post Hematopoietic Stem Cell Transplantation: Interim
Results of a Prospective Randomized Trial
David Dennison 1, Iman Maktoom Al Manthari 2,
Murtadha Al-Khabori 1, Revathi Raj 3, Sharat Damodar 4,
Alok Srivastava 5, Khalil Al Farsi 1, Mohammed Al Huneini 1,
Abdulhakeem Rawas 6, Yusra Al Habsi 2, Arwa Z. Al Riyami 1,
Aqeela Al Lawati 7, Intisar Al Riyami 7, Abdulla Balkhair 8,
Zahra Al Harthy 2, Shyam Sundar Ganguly 9, Salam Al Kindi 1.
1Hematology, Sultan Qaboos University Hospital, Muscat,
Oman; 2Nursing, Sultan Qaboos University Hospital, Muscat,
Oman; 3 Pediatric Hematology, Apollo Hopsitals, Chennai,
Chennai, Tamilnadu, India; 4 Hematology, Narayana
Hrudayalaya Hospital, Bangalore, India; 5 Department of
Haematology, Christian Medical College, Vellore, India;
